MedPath

SUPPLEMENTATION WITH BETA GLUCAN AND ADAPTATIVE RESPONSE.

Not Applicable
Not yet recruiting
Conditions
Clinical Course
Interventions
Dietary Supplement: BioNutri AR-1,
Registration Number
NCT06545149
Lead Sponsor
Federal University of São Paulo
Brief Summary

Abstract: Studies demonstrate that the use of nutritional supplements containing beta-glucans stimulates the immune system, modulates inflammatory activity, and promotes so-called immune training. Beta-glucans are prebiotics that stimulate the growth and activity of gastrointestinal microbiota and inhibit pathogen growth. Nutritional intervention is crucial for patients\' positive evolution, and providing a supplement with highly bioavailable nutrients can make a difference in their nutritional, metabolic, and immune status. Therefore, the study aims to verify the effectiveness of the innate and adaptive immune response to a nutritionally balanced fermented food, containing oral or enteral beta-glucans, in patients treated at 3 Emergency Care Units in São José do Rio Preto, São Paulo, Brazil. This is a prospective randomized study with a characteristic design involving patients treated in the medical wards of 3 Emergency Care Unit. The following assessments will be conducted: Global Subjective Assessment for adults and Mini Nutritional Assessment for the elderly, Sociodemographic, and Laboratory Evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria

Patients admitted to the medical clinic ward

Exclusion Criteria

Patients unable to swallow

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlBioNutri AR-1,The group will receive the intervention with coconut wheat
BioNutri AR-1BioNutri AR-1,The group will receive the intervention with fermented and nutritionally balanced food
Primary Outcome Measures
NameTimeMethod
length of hospital stayduring hospitalization
Secondary Outcome Measures
NameTimeMethod
need for readmissionup to 24 weeks
need for ICUup to 24 weeks
© Copyright 2025. All Rights Reserved by MedPath